Creating a device to quickly detect SARS-CoV-2 in the air
Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
This study is working on a handy device that can quickly check the air for COVID-19 particles, helping people understand and manage the virus as we get back to our daily lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Genendeavor, LLC NIH-funded |
| Lab location | 1 site (Hayward, UNITED STATES) |
| Project ID | NIH-10854070 on NIH RePORTER |
What this research studies
This research focuses on developing a handheld device that can monitor and quantify the presence of SARS-CoV-2 in aerosol particles in real-time. By utilizing advanced technologies such as rapid-kinetic chemical auto-ligation and solid-state electronics, the device aims to provide immediate results without the need for complex laboratory equipment. This capability is crucial for understanding and managing the airborne transmission of COVID-19 as communities return to normal activities. The project combines expertise from various fields to create a novel air monitoring system that could transform how we study and respond to the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in community settings, workplaces, and schools who are concerned about airborne transmission of COVID-19.
Not a fit: Patients who are not in environments where aerosol transmission is a concern may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant advancement in public health by enabling real-time monitoring of COVID-19 transmission risks in various environments.
How similar studies have performed: While there have been advancements in air monitoring technologies, this specific approach to real-time detection of SARS-CoV-2 in aerosols is novel and has not been extensively tested.
Where this research is happening
Hayward, UNITED STATES
- Genendeavor, LLC — Hayward, United States (Active)
Researchers
- Principal investigator: Mancebo, Ricardo — Genendeavor, LLC
- Study coordinator: Mancebo, Ricardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.